Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study
New members of the management team bring expertise in progressing clinical programs and executing successful biotech transactions
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.